These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19029523)

  • 1. OPA1 in multiple mitochondrial DNA deletion disorders.
    Stewart JD; Hudson G; Yu-Wai-Man P; Blakeley EL; He L; Horvath R; Maddison P; Wright A; Griffiths PG; Turnbull DM; Taylor RW; Chinnery PF
    Neurology; 2008 Nov; 71(22):1829-31. PubMed ID: 19029523
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1.
    Ferraris S; Clark S; Garelli E; Davidzon G; Moore SA; Kardon RH; Bienstock RJ; Longley MJ; Mancuso M; Gutiérrez Ríos P; Hirano M; Copeland WC; DiMauro S
    Arch Neurol; 2008 Jan; 65(1):125-31. PubMed ID: 18195150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary mtDNA defects do not cause optic nerve dysfunction in a mouse model of dominant optic atrophy.
    Yu-Wai-Man P; Davies VJ; Piechota MJ; Cree LM; Votruba M; Chinnery PF
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4561-6. PubMed ID: 19443720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.
    Hudson G; Amati-Bonneau P; Blakely EL; Stewart JD; He L; Schaefer AM; Griffiths PG; Ahlqvist K; Suomalainen A; Reynier P; McFarland R; Turnbull DM; Chinnery PF; Taylor RW
    Brain; 2008 Feb; 131(Pt 2):329-37. PubMed ID: 18065439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OPA1 mutations cause cytochrome c oxidase deficiency due to loss of wild-type mtDNA molecules.
    Yu-Wai-Man P; Sitarz KS; Samuels DC; Griffiths PG; Reeve AK; Bindoff LA; Horvath R; Chinnery PF
    Hum Mol Genet; 2010 Aug; 19(15):3043-52. PubMed ID: 20484224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape.
    Zeviani M
    Brain; 2008 Feb; 131(Pt 2):314-7. PubMed ID: 18222990
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hereditary optic atrophies].
    Scherer C; Procaccio V; Ferre M; Guillet V; Reynier P; Amati-Bonneau P; Dubas F; Bonneau D; Verny C
    Rev Neurol (Paris); 2010 Dec; 166(12):959-65. PubMed ID: 21056443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.
    Ferré M; Bonneau D; Milea D; Chevrollier A; Verny C; Dollfus H; Ayuso C; Defoort S; Vignal C; Zanlonghi X; Charlin JF; Kaplan J; Odent S; Hamel CP; Procaccio V; Reynier P; Amati-Bonneau P
    Hum Mutat; 2009 Jul; 30(7):E692-705. PubMed ID: 19319978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel OPA1 mutations identified in Japanese pedigrees with optic atrophy.
    Qin M; Kondo H; Uno H; Fujiwara E; Uchio E; Tahira T; Hayashi K
    Mol Vis; 2006 May; 12():485-91. PubMed ID: 16735988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations.
    Lodi R; Tonon C; Valentino ML; Manners D; Testa C; Malucelli E; La Morgia C; Barboni P; Carbonelli M; Schimpf S; Wissinger B; Zeviani M; Baruzzi A; Liguori R; Barbiroli B; Carelli V
    Arch Neurol; 2011 Jan; 68(1):67-73. PubMed ID: 20837821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuro-ophthalmologic manifestations of mitochondrial DNA disorders: chronic progressive external ophthalmoplegia, Kearns-Sayre syndrome, and Leber's hereditary optic neuropathy.
    Kosmorsky G; Johns DR
    Neurol Clin; 1991 Feb; 9(1):147-61. PubMed ID: 2011107
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitochondrial disorder with OPA1 mutation lacking optic atrophy.
    Milone M; Younge BR; Wang J; Zhang S; Wong LJ
    Mitochondrion; 2009 Jul; 9(4):279-81. PubMed ID: 19303950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-system neurological disease is common in patients with OPA1 mutations.
    Yu-Wai-Man P; Griffiths PG; Gorman GS; Lourenco CM; Wright AF; Auer-Grumbach M; Toscano A; Musumeci O; Valentino ML; Caporali L; Lamperti C; Tallaksen CM; Duffey P; Miller J; Whittaker RG; Baker MR; Jackson MJ; Clarke MP; Dhillon B; Czermin B; Stewart JD; Hudson G; Reynier P; Bonneau D; Marques W; Lenaers G; McFarland R; Taylor RW; Turnbull DM; Votruba M; Zeviani M; Carelli V; Bindoff LA; Horvath R; Amati-Bonneau P; Chinnery PF
    Brain; 2010 Mar; 133(Pt 3):771-86. PubMed ID: 20157015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.
    Pesch UE; Leo-Kottler B; Mayer S; Jurklies B; Kellner U; Apfelstedt-Sylla E; Zrenner E; Alexander C; Wissinger B
    Hum Mol Genet; 2001 Jun; 10(13):1359-68. PubMed ID: 11440988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.
    Amati-Bonneau P; Valentino ML; Reynier P; Gallardo ME; Bornstein B; Boissière A; Campos Y; Rivera H; de la Aleja JG; Carroccia R; Iommarini L; Labauge P; Figarella-Branger D; Marcorelles P; Furby A; Beauvais K; Letournel F; Liguori R; La Morgia C; Montagna P; Liguori M; Zanna C; Rugolo M; Cossarizza A; Wissinger B; Verny C; Schwarzenbacher R; Martín MA; Arenas J; Ayuso C; Garesse R; Lenaers G; Bonneau D; Carelli V
    Brain; 2008 Feb; 131(Pt 2):338-51. PubMed ID: 18158317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy.
    Toomes C; Marchbank NJ; Mackey DA; Craig JE; Newbury-Ecob RA; Bennett CP; Vize CJ; Desai SP; Black GC; Patel N; Teimory M; Markham AF; Inglehearn CF; Churchill AJ
    Hum Mol Genet; 2001 Jun; 10(13):1369-78. PubMed ID: 11440989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction in an Opa1(Q285STOP) mouse model of dominant optic atrophy results from Opa1 haploinsufficiency.
    Kushnareva Y; Seong Y; Andreyev AY; Kuwana T; Kiosses WB; Votruba M; Newmeyer DD
    Cell Death Dis; 2016 Jul; 7(7):e2309. PubMed ID: 27468686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A novel mutation of the OPA1 gene responsible for isolated autosomal dominant optic atrophy in two brothers].
    Macarez R; Amati-Bonneau P; Burelle X; Vanimschoot M; Dot C; Ocamica P; Kovalski JL; May F
    J Fr Ophtalmol; 2007 Feb; 30(2):161-4. PubMed ID: 17318099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial encephalomyopathy due to a novel mutation in the tRNAGlu of mitochondrial DNA.
    Pancrudo J; Shanske S; Bonilla E; Daras M; Akman HO; Krishna S; Malkin E; DiMauro S
    J Child Neurol; 2007 Jul; 22(7):858-62. PubMed ID: 17715279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.
    Payne M; Yang Z; Katz BJ; Warner JE; Weight CJ; Zhao Y; Pearson ED; Treft RL; Hillman T; Kennedy RJ; Meire FM; Zhang K
    Am J Ophthalmol; 2004 Nov; 138(5):749-55. PubMed ID: 15531309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.